Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Maxime Fredon

4PUBLICATIONS
45CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Oct 20, 2025
Targeting SALL4 with an HLA Class I-Restricted TCR for Cancer Immunotherapy.

Myriam Ben Khelil, Maxime Fredon, Nawfel Adib

|Aug 22, 2025
Venetoclax in the Therapeutic Strategy for BPDCN Management.

Margaux Poussard, Maxime Fredon, Imane Belakri

|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Maxime Fredon, Margaux Poussard, Sabeha Biichlé

|Jun 28, 2023
Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma.

Aicha Sassi, Maxime Fredon, Alexia K Cotte

Pageof 1

Frequent Collaborators

2 joint publications

Yann Godet

2 joint publications

Francine Garnache-Ottou

2 joint publications

Margaux Poussard

2 joint publications

Olivier Adotévi

2 joint publications

Charles-Frédéric Mantion

2 joint publications

Evan Seffar

2 joint publications

Philippe Saas

2 joint publications

Mathieu Gonçalves-Venturelli

1 joint publications

Laurent Martiny

1 joint publications

Dominique Delmas

Frequent Collaborators

2 joint publications

Yann Godet

2 joint publications

Francine Garnache-Ottou

2 joint publications

Margaux Poussard

2 joint publications

Olivier Adotévi

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

11.8K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

8.9K
Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
09:12

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

884
See more related videos

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

11.8K
Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema
08:44

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on : Sep 01, 2016

8.9K
Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells
09:12

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

884
See more related videos